Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization

Journal de Mycologie Medicale

Volumn 28, Issue 2, 2018, Pages 361-366

  Jahanshiri, Z ^a   Manifar, S ^b   Moosa, H ^a   Asghari Paskiabi, F ^a   Mahmoodzadeh, H ^b   Shams Ghahfarokhi, M ^c   Razzaghi Abyaneh, M ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Antifungal susceptibility; Biofilm; Candida; Head and neck cancer; Oropharyngeal candidiasis

Indexed keywords

AMPHOTERICIN B; CARBOHYDRATE; FLUCONAZOLE; GENOMIC DNA; INTERNAL TRANSCRIBED SPACER 1; ITRACONAZOLE; KETOCONAZOLE; PHOSPHOLIPASE; PROTEINASE; ANTIFUNGAL AGENT; RIBOSOMAL SPACER DNA;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ANTIFUNGAL THERAPY; ARTICLE; BIOFILM; CANCER RADIOTHERAPY; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HEAD AND NECK CANCER; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; OROPHARYNX CANDIDIASIS; PATHOGENESIS; SEQUENCE ANALYSIS; SPECIES IDENTIFICATION; COMPLICATION; DRUG EFFECT; GENETICS; HEAD AND NECK TUMOR; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; THRUSH;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS, ORAL; DNA, RIBOSOMAL SPACER; DRUG RESISTANCE, FUNGAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IRAN; MALE; MICROBIAL SENSITIVITY TESTS;

EID: 85044365338     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2018.01.001     Document Type: Article

References (39)

1. Bensadoun, R.-J., Patton, L.L., Lalla, R.V., Epstein, J.B., Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer 19 (2011), 737–744.
2. Suryawanshi, H., Ganvir, S.M., Hazarey, V.K., Wanjare, V.S., Oropharyngeal candidosis relative frequency in radiotherapy patient for head and neck cancer. J Oral Maxillofac Pathol 16 (2012), 31–37.
3. Tati, S., Davidow, P., McCall, A., Hwang-Wong, E., Rojas, I.G., Cormack, B., Candida glabrata binding to Candida albicans hyphae enables its development in oropharyngeal Candidiasis. PLoS Pathog, 12, 2016, e1005522.
4. Asadzadeh, M., Ahmad, S., Hagen, F., Meis, J.F., Al-Sweih, N., Khan, Z., Simple, low-cost detection of Candida parapsilosis complex isolates and molecular fingerprinting of Candida orthopsilosis strains in Kuwait by ITS region sequencing and amplified fragment length polymorphism analysis. PloS One, 10, 2015, e0142880.
5. Dahiya, M.C., Redding, S.W., Dahiya, R.S., Eng, T.Y., Kirkpatrick, W.R., Coco, B.J., Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 57 (2003), 79–83.
6. Pfaller, M., Andes, D., Diekema, D., Espinel-Ingroff, A., Sheehan, D., Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for Fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 13 (2010), 180–195.
7. Wang, Y., Shi, C., Liu, J.-Y., Li, W.-J., Zhao, Y., Xiang, M.-J., Multilocus sequence typing of Candida tropicalis shows clonal cluster enrichment in azole-resistant isolates from patients in Shanghai, China. Infect Genet Evol 44 (2016), 418–424.
8. Jahn, B., Martin, E., Stueben, A., Bhakdi, S., Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol 33 (1995), 661–667.
9. Kujath, P., Boos, C., Lerch, K., Kochendörfer, P., Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 21 (1993), 376–382.
10. Versalovic, J., Koeuth, T., Lupski, R., Distribution of repetitive DNA sequences in eubacteria and application to finerpriting of bacterial enomes. Nucleic Acids Res 19 (1991), 6823–6831.
11. Saitou, N., Nei, M., The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol 4 (1987), 406–425.
12. Jin, Y., Yip, H., Samaranayake, Y., Yau, J., Samaranayake, L., Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 41 (2003), 2961–2967.
13. Tumbarello, M., Posteraro, B., Trecarichi, E.M., Fiori, B., Rossi, M., Porta, R., Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45 (2007), 1843–1850.
14. Price, M.F., Wilkinson, I.D., Gentry, L.O., Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20 (1982), 7–14.
15. Pereira, C.A., Costa, A.C., Machado, A.K., Beltrame, M.J., Zöllner, M.S., Junqueira, J.C., Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers’ mouths and nipples. Mycopathologia 171 (2011), 103–109.
16. Ruchell, R., Tegeller, R., Trost, M.A., A comparison of secretory proteinases from different strains of Candida albicans. Sabouraudia 20 (1982), 233–244.
17. Nicolatou-Galitis, O., Sotiropoulou-Lontou, A., Velegraki, A., Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. Oral Oncol 39 (2003), 397–401.
18. Nicolatou-Galitis, O., Dardoufas, K., Markoulatos, P., Sotiropoulou-Lontou, A., Kyprianou, A., Kolitsi, G., Oral pseudomembranous candidiasis, herpes simplex virus-1 infection and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med 30 (2001), 471–480.
19. Leaw, S.N., Chang, H.C., Sun, H.F., Barton, R., Bouchara, J.-P., Chang, T.C., Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 44 (2006), 693–699.
20. Redding, S.W., Dahiya, M.C., Kirkpatrick, W.R., Coco, B.J., Patterson, T.F., Fothergill, A.W., Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 97 (2004), 47–52.
21. Schelenz, S., Abdallah, S., Gray, G., Stubbings, H., Gow, I., Baker, P., Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors. J Oral Pathol Med 40 (2011), 83–89.
22. Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28 (1999), 1071–1079.
23. Deorukhkar, S., Saini, S., Virulence markers and antifungal ausceptibility profile of Candida glabrata: an emerging pathogen. Br Microbiol Res J 4 (2014), 39–49.
24. Kothavade, R.J., Kura, M., Valand, A.G., Panthaki, M., Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol 59 (2010), 873–880.
25. Chakrabartt, A., Singh, K., Narang, A., Singhi, S., Atra, B.R., Rao, M.M., et al. Outbreak of Pichia anomala infection in the Pediatric Service of a tertiary-care center in Northern India. J Clin Microbiol 39 (2001), 1702–1706.
26. Sherry, L., Rajendran, R., Lappin, D.F., Borghi, E., Perdoni, F., Falleni, M., Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiol 14 (2014), 182–196.
27. Samaranayake, L.P., Raeside, J.M., MacFarlane, T.W., Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 22 (1984), 201–207.
28. Yu, S., Li, W., Che, J., Bian, F., Lu, J., Wu, Y., Study on virulence factors of Candida tropicalis isolated from clinical samples. Zhonghua Liu Xing Bing Xue Za Zhi 36 (2015), 1162–1166.
29. Jiang, C., Li, Z., Zhang, L., Tian, Y., Dong, D., Peng, Y., Significance of hyphae formation in virulence of Candida tropicalis and transcriptomic analysis of hyphal cells. Microbiol Res 192 (2016), 65–72.
30. Galan-Ladero, M.A., Blanco-Blanco, M.T., Hurtado, C., Perez-Giraldo, C., Blanco, M.T., Gomez-Garcia, A.C., Determination of biofilm production by Candida tropicalis isolated from hospitalized patients and its relation to cellular surface hydrophobicity, plastic adherence and filamentation ability. Yeast 30 (2013), 331–339.
31. Kumar, C.P.G., Sundararajan, T., Menon, T., Venkatadesikalu, M., Candidosis in children with onco-hematological diseases in Chennai, South India. Jpn J Infect Dis 58 (2005), 218–221.
32. Razzaghi-Abyaneh, M., Sadeghi, G., Zeinali, E., Alirezaee, M., Shams-Ghahfarokhi, M., Amani, A., et al. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran. J Mycol Med 24 (2014), e43–e50.
33. Kurnatowska, A., Kurnatowski, P., Horwatta-Bozyczko, E., Kurnatowska, A.J., Minimal inhibitory concentration (MIC) of caspofungin and itraconazole inhibiting growth of Candida strains calculated from the linear regression equation. Adv Med Sci 57 (2012), 148–151.
34. Redding, S.W., Kirkpatrick, W.R., Dib, O., Fothergill, A.W., Rinaldi, M.G., Patterson, T.F., The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients. Spec Care Dentist 20 (2000), 178–181.
35. Shokohi, T., Badali, H., Amirrajab, N., Ataollahi, M.R., Kouhpayeh, S.A., Afsarian, M.H., In vitro activity of five antifungal agents against Candida albicans isolates, Sari, Iran. Curr Med Mycol 2 (2016), 34–39.
36. Canela, H.M.S., Cardoso, B., Vitali, L.H., Coelho, H.C., Martinez, R., Ferreira MEDS. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. Mycoses 61 (2018), 11–21.
37. Nolte, F.S., Parkinson, T., Falconer, J.D., Dix, S., Williams, J., Gilmore, C., et al. Isolation and characterization of fluconazole – and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 44 (1997), 196–199.
38. Fan-Havard, P., Capano, D., Smith, M.S., Mangia, A., Engi, R.H.K., Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 35 (1991), 2302–2305.
39. Zida, A., Yacouba, A., Bamba, S., Sangare, I., Sawadogo, M., Guiguemde, T., et al. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). J Mycol Med 27 (2017), 469–475.